---
layout: post
title: "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Brorphine; Metonitazene; Eutylone; Request for Comments"
date: 2026-02-05 18:58:06 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-03229
original_published: 2022-02-15 00:00:00 +0000
significance: 8.00
---

# International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Brorphine; Metonitazene; Eutylone; Request for Comments

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** February 15, 2022 00:00 UTC
**Document Number:** 2022-03229

## Summary

The Food and Drug Administration (FDA) is providing interested persons with the opportunity to submit written comments concerning recommendations by the World Health Organization (WHO) to impose international manufacturing and distributing restrictions, under international treaties, on certain drug substances. The comments received in response to this notice will be considered in preparing the United States' position on these proposals for a meeting of the United Nations Commission on Narcotic Drugs (CND) in Vienna, Austria, in March 2022. This notice is issued under the Controlled Substances Act (CSA).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/02/15/2022-03229/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic)
- API: https://www.federalregister.gov/api/v1/documents/2022-03229

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
